Developing a Shared Decision Making Tool for Patients With Surgically Removed Non-small Cell Lung Cancer
NCT ID: NCT05416983
Last Updated: 2025-10-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
37 participants
OBSERVATIONAL
2022-02-17
2023-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Shared Decision Making in Patients With Lung Cancer
NCT05191485
Decision Aid for the Improvement of Decision-Making in Patients With Non-small Cell Lung Cancer
NCT04946279
Measurement of Pain and Other Symptoms of Non-Small Cell Lung Cancer (NSCLC) Patients Following Thoracic Surgery
NCT00501319
Improving Decision-Making Encounters in Lung Cancer Using a Low-Literacy Conversation Tool
NCT05407168
Lung Cancer Surgery: Decisions Against Life Saving Care - The Intervention
NCT01687738
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
I. To develop, in close collaboration with stakeholders, an evidence-based decision aid to inform discussions regarding options for adjuvant treatment in patients with resected non-small cell lung cancer (NSCL) (NSCL adjuvant choice).
OUTLINE:
Patient and clinician discussions are observed to support refinement of a decision aid. Clinicians may use a prototype of the decision aid in discussions with their patients and may complete a questionnaire.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Observational (discussion)
Patient and clinician discussions are observed to support refinement of a decision aid. Clinicians may use a prototype of the decision aid in discussions with their patients and may complete a questionnaire.
Discussion
Attend discussion
Questionnaire Administration
Complete questionnaire
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Discussion
Attend discussion
Questionnaire Administration
Complete questionnaire
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Adults \>= 18 years with biopsy proven resected non-small cell lung cancer (NSCLC)
* Appointments to discuss adjuvant treatment of resected NSCLC
* CLINICIANS:
* Clinicians who meet with patients to discuss adjuvant treatment of resected NSCLC
* PAG MEMBERS:
* Adults \>= 18 years
* Member of the Knowledge and Evaluation Research (KER) Unit Patient Advisory Group (PAG)
Exclusion Criteria
* Major barriers to providing informed consent (i.e., dementia, severe hearing or visual impairment)
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mayo Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Konstantinos Leventakos, M.D.
Role: PRINCIPAL_INVESTIGATOR
Mayo Clinic in Rochester
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mayo Clinic in Rochester
Rochester, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Mayo Clinic Clinical Trials
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2022-01685
Identifier Type: REGISTRY
Identifier Source: secondary_id
21-013359
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.